| Metric | Value (₹ Cr) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 1.7K | 7.8% | 25.2% |
| Total Income | 1.7K | 10.8% | 28.1% |
| Expenditure | 1.4K | 3.8% | 17.8% |
| PBT | 326.81 | 55.3% | 103.7% |
| Net Profit | 250.83 | 68.8% | 113.8% |
| OPM | 25.03% | 2.54pp | 25.86pp |
| NPM | 14.61% | 5.02pp | 5.86pp |
| EPS | 0.53 | 65.6% | 112.0% |
Sagility Ltd Reports 25.2% YoY Revenue Growth in Q2FY26 & H1 FY26 Consolidated)
29 Oct 2025 · 29 Oct 2025, 07:33 pm
Summary
Sagility Ltd, a leading global provider of technology-enabled business solutions and services to clients in the U.S healthcare Industry, reported its consolidated financial results for the quarter ended Sep 30, 2025. The company reported a YoY revenue growth of 25.2% (20.0% in CC terms), Adjusted EBITDA at 26.2% with 25.6% YoY growth, and Adjusted PAT at 18.1% with 84.0% YoY growth.
Key Highlights
- 1
Revenue at INR 21,658 million (US$ 189.4 million), YoY growth of 25.2% (20.0% in CC terms)
- 2
Organic YoY growth of 16.0% (11.1% in CC terms)
- 3
Adjusted EBITDA at INR 4,352 million (USS 49.8 million) at 26.2% of revenue, YoY growth of 25.6%
- 4
Adjusted PAT at INR 3,010 million (US$ 34.5 million) at 18.1% of revenue, YoY growth of 84.0%
- 5
Interim Dividend of INR 0.05 per share
- 6
44,185 employees
- 7
Presence in 5 countries with 34 delivery centers
- 8
Awarded Great Place to Work-Certified™ in India in Sept 2025
- 9
Winner of the Asia CEO Awards 2025 - “Service Excellence Company of the Year” for Sagility Philippines
Management Comments
Ramesh Gopalan
Managing Director and Group CEO
Our performance through the first half of FY26 underscores Sagility’s ability to sustain a healthy growth in a changing marketplace. As our clients continue to deal with profitability pressures, we are bringing our domain expertise and transformational capabilities to help them reduce cost of operations.
Sarvabhouman Srinivasan
Group Chief Financial Officer
Our margin profile continues to be robust, alongside strong growth. This is a result of disciplined cost management initiatives and operational efficiencies. We continue to generate strong operating cash flows and maintain a healthy balance sheet while progressively lowering debt. We will continue to invest in driving growth, further strengthening our technology and AI capabilities, and building an AI-ready healthcare-centric future workforce.
Informational and educational content only. Not investment advice.